Anteris Technologies Global Corp.

AVR ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-29.1M $-23.0M $-29.2M $-22.2M $-20.8M $-21.9M $-19.4M $-21.9M
Depreciation & Amortization $469.0K $429.0K $423.0K $417.0K $418.0K $403.0K $404.0K $381.0K
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $2.1M $1.8M $3.0M $1.5M $1.5M $1.7M $1.3M $2.0M
Net Cash from Operating Activities $-20.8M $-28.7M $-18.5M $-18.3M $-19.5M $-21.5M $-18.2M $-14.1M
Investing Activities
Capital Expenditures $648.0K $137.0K $397.0K $772.0K $537.0K $248.0K $363.0K $540.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-648.0K $-182.0K $-397.0K $-772.0K $-537.0K $1.1M $-364.0K $-553.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-877.0K $299.5M $22.4M $-294.0K $-442.0K $-1.1M $78.4M $18.5M
Net Change in Cash $-22.3M $270.6M $3.5M $-19.3M $-20.5M $-21.5M $59.8M $3.4M
Free Cash Flow $-21.4M $-28.8M $-18.9M $-19.0M $-20.1M $-21.7M $-18.6M $-14.6M
← Newer Page 1 of 2 Older →